Small molecules present in the cerebrospinal fluid metabolome influence superoxide dismutase 1 aggregation

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 19128-19145

  Cristóvão, Joana S ^a   Leal, Sónia S ^a   Cardoso, Isabel ^b,c   Gomes, Cláudio M ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

Author keywords

Amyloid; Dynamic light scattering; Nanoparticle tracking analysis; Neurodegeneration; Protein aggregation; Small molecules; Transmission electron microscopy

Indexed keywords

ARGININE; COPPER ZINC SUPEROXIDE DISMUTASE; LYSINE; ORNITHINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; GENE MUTATION; METABOLOME; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; PROTEIN TERTIARY STRUCTURE; THERMOSTABILITY;

AMINO ACIDS; AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; METABOLOME; MONOSACCHARIDES; MUTATION; PROTEIN BINDING; SUGAR ACIDS; SUPEROXIDE DISMUTASE;

EID: 84884562833     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140919128     Document Type: Article

References (65)

1. Kato, S.; Takikawa, M.; Nakashima, K.; Hirano, A.; Cleveland, D.W.; Kusaka, H.; Shibata, N.; Kato, M.; Nakano, I.; Ohama, E. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (sod1) gene mutations: Inclusions containing sod1 in neurons and astrocytes. Amyotrophic Lateral Scler. Other Mot. Neuron Disord. 2000, 1, 163-184.
2. Rosen, D.R.; Siddique, T.; Patterson, D.; Figlewicz, D.A.; Sapp, P.; Hentati, A.; Donaldson, D.; Goto, J.; O'Regan, J.P.; Deng, H.X.; et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362, 59-62.
3. Forsberg, K.; Jonsson, P.A.; Andersen, P.M.; Bergemalm, D.; Graffmo, K.S.; Hultdin, M.; Jacobsson, J.; Rosquist, R.; Marklund, S.L.; Brannstrom, T. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic als patients. PLoS One 2010, 5, e11552.
4. Shibata, N.; Asayama, K.; Hirano, A.; Kobayashi, M. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev. Neurosci. 1996, 18, 492-498.
5. Forsberg, K.; Andersen, P.M.; Marklund, S.L.; Brannstrom, T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2011, 121, 623-634.
6. Kabashi, E.; Valdmanis, P.N.; Dion, P.; Rouleau, G.A. Oxidized/misfolded superoxide dismutase-1: The cause of all amyotrophic lateral sclerosis? Ann. Neurol. 2007, 62, 553-559.
7. Gruzman, A.; Wood, W.L.; Alpert, E.; Prasad, M.D.; Miller, R.G.; Rothstein, J.D.; Bowser, R.; Hamilton, R.; Wood, T.D.; Cleveland, D.W.; et al. Common molecular signature in sod1 for both sporadic and familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 2007, 104, 12524-12529.
8. Watanabe, M.; Dykes-Hoberg, M.; Culotta, V.C.; Price, D.L.; Wong, P.C.; Rothstein, J.D. Histological evidence of protein aggregation in mutant sod1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 2001, 8, 933-941.
9. Bruijn, L.I.; Houseweart, M.K.; Kato, S.; Anderson, K.L.; Anderson, S.D.; Ohama, E.; Reaume, A.G.; Scott, R.W.; Cleveland, D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998, 281, 1851-1854.
10. Ilieva, H.; Polymenidou, M.; Cleveland, D.W. Non-cell autonomous toxicity in neurodegenerative disorders: Als and beyond. J. Cell Biol. 2009, 187, 761-772.
11. Felbecker, A.; Camu, W.; Valdmanis, P.N.; Sperfeld, A.D.; Waibel, S.; Steinbach, P.; Rouleau, G.A.; Ludolph, A.C.; Andersen, P.M. Four familial als pedigrees discordant for two SOD1 mutations: Are all SOD1 mutations pathogenic? J. Neurol. Neurosurg. Psychiatry 2010, 81, 572-577.
12. Roberts, K.; Zeineddine, R.; Corcoran, L.; Li, W.; Campbell, I.L.; Yerbury, J.J. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia 2013, 61, 409-419.
13. Munch, C.; O'Brien, J.; Bertolotti, A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. USA 2011, 108, 3548-3553.
14. Wuolikainen, A.; Andersen, P.M.; Moritz, T.; Marklund, S.L.; Antti, H. Als patients with mutations in the sod1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with als patients without mutations. Mol. Genet. Metab. 2012, 105, 472-478.
15. Tarasiuk, J.; Kulakowska, A.; Drozdowski, W.; Kornhuber, J.; Lewczuk, P. Csf markers in amyotrophic lateral sclerosis. J. Neural Transm. 2012, 119, 747-757.
16. Wuolikainen, A.; Moritz, T.; Marklund, S.L.; Antti, H.; Andersen, P.M. Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by gc/tofms. PLoS One 2011, 6, e17947.
17. Niessen, H.G.; Debska-Vielhaber, G.; Sander, K.; Angenstein, F.; Ludolph, A.C.; Hilfert, L.; Willker, W.; Leibfritz, D.; Heinze, H.J.; Kunz, W.S.; et al. Metabolic progression markers of neurodegeneration in the transgenic g93a-sod1 mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2007, 25, 1669-1677.
18. Mondola, P.; Ruggiero, G.; Seru, R.; Damiano, S.; Grimaldi, S.; Garbi, C.; Monda, M.; Greco, D.; Santillo, M. The Cu, Zn superoxide dismutase in neuroblastoma SK-N-BE cells is exported by a microvesicles dependent pathway. Brain Res. Mol. Brain Res. 2003, 110, 45-51.
19. Urushitani, M.; Sik, A.; Sakurai, T.; Nukina, N.; Takahashi, R.; Julien, J.P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 2006, 9, 108-118.
20. Jacobsson, J.; Jonsson, P.A.; Andersen, P.M.; Forsgren, L.; Marklund, S.L. Superoxide dismutase in csf from amyotrophic lateral sclerosis patients with and without Cu/Zn-superoxide dismutase mutations. Brain 2001, 124, 1461-1466.
21. Zetterström, P.; Andersen, P.M.; Brännström, T.; Marklund, S.L. Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. J. Neurochem. 2011, 117, 91-99.
22. Gomes, C.M. Protein misfolding in disease and small molecule therapies. Curr. Top. Med. Chem. 2012, 12, 2460-2469.
23. Rodrigues, J.V.; Henriques, B.J.; Lucas, T.G.; Gomes, C.M. Cofactors and metabolites as protein folding helpers in metabolic diseases. Curr. Top. Med. Chem. 2012, 12, 2546-2559.
24. Lucas, T.G.; Henriques, B.J.; Rodrigues, J.V.; Bross, P.; Gregersen, N.; Gomes, C.M. Cofactors and metabolites as potential stabilizers of mitochondrial acyl-coa dehydrogenases. Biochim. Biophys. Acta 2011, 1812, 1658-1663.
25. Leandro, P.; Gomes, C.M. Protein misfolding in conformational disorders: Rescue of folding defects and chemical chaperoning. Mini Rev. Med. Chem. 2008, 8, 901-911.
26. Leal, S.S.; Botelho, H.M.; Gomes, C.M. Metal ions as modulators of protein conformation and misfolding in neurodegeneration. Coord. Chem. Rev. 2012, 256, 2253-2270.
27. Klunk, W.E.; Xu, C.J.; McClure, R.J.; Panchalingam, K.; Stanley, J.A.; Pettegrew, J.W. Aggregation of beta-amyloid peptide is promoted by membrane phospholipid metabolites elevated in Alzheimer's disease brain. J. Neurochem. 1997, 69, 266-272.
28. Kim, H.Y.; Kim, Y.; Han, G.; Kim, D.J. Regulation of in vitro abeta1-40 aggregation mediated by small molecules. J. Alzheimer's Dis. 2010, 22, 73-85.
29. Kawasaki, T.; Kamijo, S. Inhibition of aggregation of amyloid beta42 by arginine-containing small compounds. Biosci. Biotechnol. Biochem. 2012, 76, 762-766.
30. Fung, J.; Darabie, A.A.; McLaurin, J. Contribution of simple saccharides to the stabilization of amyloid structure. Biochem. Biophys. Res. Commun. 2005, 328, 1067-1072.
31. Murakami, G.; Inoue, H.; Tsukita, K.; Asai, Y.; Amagai, Y.; Aiba, K.; Shimogawa, H.; Uesugi, M.; Nakatsuji, N.; Takahashi, R. Chemical library screening identifies a small molecule that downregulates sod1 transcription for drugs to treat amyotrophic lateral sclerosis. J. Biomol. Screen. 2011, 16, 405-414.
32. Limpert, A.S.; Mattmann, M.E.; Cosford, N.D. Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS). Beilstein J. Org. Chem. 2013, 9, 717-732.
33. Ray, S.S.; Nowak, R.J.; Brown, R.H., Jr.; Lansbury, P.T., Jr. Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. Proc. Natl. Acad. Sci. USA 2005, 102, 3639-3644.
34. Wittung-Stafshede, P. Protein folding inside the cell. Biophys. J. 2011, 101, 265-266.
35. Parone, P.A.; da Cruz, S.; Han, J.S.; McAlonis-Downes, M.; Vetto, A.P.; Lee, S.K.; Tseng, E.; Cleveland, D.W. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J. Neurosci. 2013, 33, 4657-4671.
36. Tradewell, M.L.; Cooper, L.A.; Minotti, S.; Durham, H.D. Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: Mechanistic relationship and differential sensitivity to intervention. Neurobiol. Dis. 2011, 42, 265-275.
37. Leal, S.S.; Cardoso, I.; Valentine, J.S.; Gomes, C.M. Calcium ions promote superoxide dismutase 1 (SOD1) aggregation into non fibrillar amyloid: A link to toxic effects of calcium overload in amyotrophic lateral sclerosis (ALS)? J. Biol. Chem. 2013, 288, 25219-25228.
38. Furukawa, Y.; Kaneko, K.; Yamanaka, K.; O'Halloran, T.V.; Nukina, N. Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 2008, 283, 24167-24176.
39. Furukawa, Y.; O'Halloran, T.V. Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo-and reduced form of SOD1, leading to unfolding and oxidative aggregation. J. Biol. Chem. 2005, 280, 17266-17274.
40. Jonsson, P.A.; Graffmo, K.S.; Andersen, P.M.; Brannstrom, T.; Lindberg, M.; Oliveberg, M.; Marklund, S.L. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 2006, 129, 451-464.
41. Lelie, H.L.; Liba, A.; Bourassa, M.W.; Chattopadhyay, M.; Chan, P.K.; Gralla, E.B.; Miller, L.M.; Borchelt, D.R.; Valentine, J.S.; Whitelegge, J.P. Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice. J. Biol. Chem. 2011, 286, 2795-2806.
42. Wishart, D.S.; Jewison, T.; Guo, A.C.; Wilson, M.; Knox, C.; Liu, Y.; Djoumbou, Y.; Mandal, R.; Aziat, F.; Dong, E.; et al. Hmdb 3.0-The human metabolome database in 2013. Nucleic Acids Res. 2013, 41, D801-D807.
43. Street, T.O.; Bolen, D.W.; Rose, G.D. A molecular mechanism for osmolyte-induced protein stability. Proc. Natl. Acad. Sci. USA 2006, 103, 13997-14002.
44. Durazo, A.; Shaw, B.F.; Chattopadhyay, M.; Faull, K.F.; Nersissian, A.M.; Valentine, J.S.; Whitelegge, J.P. Metal-free superoxide dismutase-1 and three different amyotrophic lateral sclerosis variants share a similar partially unfolded beta-barrel at physiological temperature. J. Biol. Chem. 2009, 284, 34382-34389.
45. Hawe, A.; Sutter, M.; Jiskoot, W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm. Res. 2008, 25, 1487-1499.
46. Tiwari, A.; Xu, Z.; Hayward, L.J. Aberrantly increased hydrophobicity shared by mutants of Cu, Zn-superoxide dismutase in familial amyotrophic lateral sclerosis. J. Biol. Chem. 2005, 280, 29771-29779.
47. Munch, C.; Bertolotti, A. Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants. J. Mol. Biol. 2010, 399, 512-525.
48. LeVine, H., 3rd. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309, 274-284.
49. LeVine, H., 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 1993, 2, 404-410.
50. Biancalana, M.; Koide, S. Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta 2010, 1804, 1405-1412.
51. Jan, A.; Gokce, O.; Luthi-Carter, R.; Lashuel, H.A. The ratio of monomeric to aggregated forms of abeta40 and abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J. Biol. Chem. 2008, 283, 28176-28189.
52. Maezawa, I.; Hong, H.S.; Liu, R.; Wu, C.Y.; Cheng, R.H.; Kung, M.P.; Kung, H.F.; Lam, K.S.; Oddo, S.; Laferla, F.M.; et al. Congo red and thioflavin-t analogs detect abeta oligomers. J. Neurochem. 2008, 104, 457-468.
53. Pedersen, J.S.; Dikov, D.; Flink, J.L.; Hjuler, H.A.; Christiansen, G.; Otzen, D.E. The changing face of glucagon fibrillation: Structural polymorphism and conformational imprinting. J. Mol. Biol. 2006, 355, 501-523.
54. Sandelin, E.; Nordlund, A.; Andersen, P.M.; Marklund, S.S.; Oliveberg, M. Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins. J. Biol. Chem. 2007, 282, 21230-21236.
55. Das, U.; Hariprasad, G.; Ethayathulla, A.S.; Manral, P.; Das, T.K.; Pasha, S.; Mann, A.; Ganguli, M.; Verma, A.K.; Bhat, R.; et al. Inhibition of protein aggregation: Supramolecular assemblies of arginine hold the key. PLoS One 2007, 2, e1176.
56. Tsumoto, K.; Ejima, D.; Kita, Y.; Arakawa, T. Review: Why is arginine effective in suppressing aggregation? Protein Pept. Lett. 2005, 12, 613-619.
57. Shah, D.; Shaikh, A.R.; Peng, X.; Rajagopalan, R. Effects of arginine on heat-induced aggregation of concentrated protein solutions. Biotechnol. Prog. 2011, 27, 513-520.
58. Chattopadhyay, M.; Durazo, A.; Sohn, S.H.; Strong, C.D.; Gralla, E.B.; Whitelegge, J.P.; Valentine, J.S. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc. Natl. Acad. Sci. USA 2008, 105, 18663-18668.
59. Oztug Durer, Z.A.; Cohlberg, J.A.; Dinh, P.; Padua, S.; Ehrenclou, K.; Downes, S.; Tan, J.K.; Nakano, Y.; Bowman, C.J.; Hoskins, J.L.; et al. Loss of metal ions, disulfide reduction and mutations related to familial als promote formation of amyloid-like aggregates from superoxide dismutase. PLoS One 2009, 4, e5004.
60. Filipe, V.; Hawe, A.; Jiskoot, W. Critical evaluation of nanoparticle tracking analysis (NTA) by nanosight for the measurement of nanoparticles and protein aggregates. Pharm. Res. 2010, 27, 796-810.
61. Elam, J.; Taylor, A.; Strange, R.; Antonyuk, S.; Doucette, P.; Rodriguez, J.; Hasnain, S.; Hayward, L.; Valentine, J.; Yeates, T.; et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat. Struct. Biol. 2003, 10, 461-467.
62. Chan, P.K.; Chattopadhyay, M.; Sharma, S.; Souda, P.; Gralla, E.B.; Borchelt, D.R.; Whitelegge, J.P.; Valentine, J.S. Structural similarity of wild-type and ALS-mutant superoxide dismutase-1 fibrils using limited proteolysis and atomic force microscopy. Proc. Natl. Acad. Sci. USA 2013, 110, 10934-10939.
63. Ahl, I.M.; Lindberg, M.J.; Tibell, L.A. Coexpression of yeast copper chaperone (YCCS) and Cu/Zn-superoxide dismutases in Escherichia coli yields protein with high copper contents. Protein Expression Purif. 2004, 37, 311-319.
64. Potter, S.Z.; Zhu, H.; Shaw, B.F.; Rodriguez, J.A.; Doucette, P.A.; Sohn, S.H.; Durazo, A.; Faull, K.F.; Gralla, E.B.; Nersissian, A.M.; et al. Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. J. Am. Chem. Soc. 2007, 129, 4575-4583.
65. Sabel, C.E.; Neureuther, J.M.; Siemann, S. A spectrophotometric method for the determination of zinc, copper, and cobalt ions in metalloproteins using zincon. Anal. Biochem. 2010, 397, 218-226.